CRUCIANI FABOZZI, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 168
AS - Asia 117
EU - Europa 106
SA - Sud America 12
AF - Africa 5
Totale 408
Nazione #
US - Stati Uniti d'America 162
SG - Singapore 46
CN - Cina 41
IT - Italia 32
IE - Irlanda 20
SE - Svezia 18
DE - Germania 16
HK - Hong Kong 8
TR - Turchia 8
BR - Brasile 7
CA - Canada 5
FI - Finlandia 5
IN - India 5
VN - Vietnam 5
GB - Regno Unito 4
NL - Olanda 4
ZA - Sudafrica 4
FR - Francia 3
VE - Venezuela 2
AM - Armenia 1
BO - Bolivia 1
EC - Ecuador 1
ES - Italia 1
IQ - Iraq 1
JP - Giappone 1
KE - Kenya 1
LK - Sri Lanka 1
MX - Messico 1
PL - Polonia 1
PY - Paraguay 1
RU - Federazione Russa 1
UA - Ucraina 1
Totale 408
Città #
Ashburn 31
Singapore 30
Chandler 24
Dublin 20
Ann Arbor 14
Santa Clara 12
Dallas 11
Munich 11
Beijing 10
Hong Kong 8
Dearborn 7
Izmir 7
Parma 7
New York 6
Turku 5
Johannesburg 4
Los Angeles 4
Nanchang 4
Shanghai 4
Wilmington 4
Boardman 3
Bremen 3
Hebei 3
Livorno 3
Milan 3
Princeton 3
Pune 3
Redwood City 3
Toronto 3
Hanoi 2
Hefei 2
Ho Chi Minh City 2
Nanjing 2
Rockville 2
Segrate 2
Amsterdam 1
Ankara 1
Anyang 1
Asunción 1
Atlanta 1
Baghdad 1
Belford Roxo 1
Belém 1
Boston 1
Brooklyn 1
Buffalo 1
Caracas 1
Changsha 1
Charlotte 1
Chennai 1
Colombo 1
Des Moines 1
Fairfield 1
Falls Church 1
Frankfurt am Main 1
Guangzhou 1
Haikou 1
Jinan 1
Kunming 1
La Guaira 1
La Paz 1
Leawood 1
Leme 1
London 1
Maceió 1
Maricá 1
Mexico City 1
Montreal 1
Nairobi 1
Nam Định 1
Ningbo 1
Nova Friburgo 1
Nuremberg 1
Orem 1
Philadelphia 1
Quito 1
Rio Saliceto 1
Rome 1
Salvador 1
San Mateo 1
Stockholm 1
Tianjin 1
Tokyo 1
Turin 1
Warsaw 1
Wigan 1
Woodbridge 1
Yerevan 1
Zhengzhou 1
Totale 316
Nome #
Latent tuberculosis infection in patients with chronic plaque psoriasis: Evidence from the Italian Psocare Registry 161
Efficacy of switching between tumor necrosis factor-alfa inhibitors in psoriasis: Results from the Italian Psocare Registry 138
Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients 118
Totale 417
Categoria #
all - tutte 1.678
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.678


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202117 0 0 0 0 0 2 1 3 6 2 3 0
2021/202218 0 0 4 1 0 0 0 1 2 2 1 7
2022/202370 7 9 4 10 5 9 1 2 21 1 1 0
2023/202425 1 1 0 1 4 8 1 0 2 2 1 4
2024/202591 2 6 6 4 12 9 0 3 12 12 10 15
2025/2026121 29 28 14 17 27 6 0 0 0 0 0 0
Totale 417